株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

耳感染症:世界の治験動向

Ear Infections Global Clinical Trials Review, H2, 2017

発行 GlobalData 商品コード 339412
出版日 ページ情報 英文 54 Pages
即納可能
価格
本日の銀行送金レート: 1USD=114.89円で換算しております。
Back to Top
耳感染症:世界の治験動向 Ear Infections Global Clinical Trials Review, H2, 2017
出版日: 2017年07月31日 ページ情報: 英文 54 Pages
概要

当レポートでは、耳感染症の治験に関する最新動向について分析しており、各地域の主要国における治験件数、治験の段階別進行状況、被験者採用の状況、有望なスポンサー、各企業や研究機関における研究の進行状況、有望な薬剤の比較といった情報をまとめています。

イントロダクション

  • 耳感染症
  • 当レポートの概要

各地域における治験状況

  • 各国の治験件数と平均被験者数
    • アジア太平洋地域の主要国における治験件数
    • 欧州の主要国における治験件数
    • 北米の主要国における治験件数
    • 中東・アフリカの主要国における治験件数

G7諸国での治験件数:耳鼻咽喉科疾患治療薬の治験における耳感染症の割合

G7諸国における段階別の治験件数

G7諸国での治験件数:進捗状況別

E7諸国での治験件数:耳鼻咽喉科疾患治療薬の治験における耳感染症の割合

E7諸国における段階別の治験件数

E7諸国での治験件数:進捗状況別

段階別の治験件数

  • 進行中の治験:段階別

進捗状況別の治験件数

治験の目標の達成状況

一定期間に採用された被験者

スポンサーの種類別の治験件数

有望なスポンサー

耳感染症治療薬の治験に携わっている主要企業

有望な薬剤

治験のプロファイル

  • 主要企業の治験の概要
    • Teva Pharmaceutical Industries Limited
    • GlaxoSmithKline Plc
    • MerLion Pharmaceuticals Pte Ltd
    • Merck & Co., Inc.
    • Laboratorios SALVAT S.A.
    • Highmark Inc.
    • Dr. Reddy's Laboratories Limited
    • Biocontrol Limited (Inactive)
    • Bfactory Health Products B.V.
    • AmpliPhi Biosciences Corporation
  • 代表的な研究機関・病院の治験の概要
    • Babol University of Medical Sciences
    • Children's Oncology Group
    • Fremantle Hospital and Health Service
    • Guilan University of Medical Sciences
    • Maastricht University Medical Center
    • Medical Research Council
    • Medical University of Vienna
    • Nilratan Sircar Medical College
    • Texas Tech University Health Sciences Center
    • University of Oxford

5つの代表的な治験のプロファイル

付録

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GDHC4419CTIDB

GlobalData's clinical trial report, "Ear Infections Global Clinical Trials Review, H2, 2017" provides an overview of Ear Infections clinical trials scenario. This report provides top line data relating to the clinical trials on Ear Infections. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents

Table of Contents 2

  • List of Tables 3
  • List of Figures 4
  • Report Guidance 5
  • GlobalData Clinical Trials Report Coverage 6
  • Clinical Trials by Region 7
  • Clinical Trials and Average Enrollment by Country 8
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
  • Top Five Countries Contributing to Clinical Trials in Europe 12
  • Top Countries Contributing to Clinical Trials in North America 13
  • Top Countries Contributing to Clinical Trials in Middle East and Africa 14
  • Clinical Trials by G7 Countries: Proportion of Ear Infections to Ear Nose Throat Disorders Clinical Trials 15
  • Clinical Trials by Phase in G7 Countries 17
  • Clinical Trials in G7 Countries by Trial Status 18
  • Clinical Trials by E7 Countries: Proportion of Ear Infections to Ear Nose Throat Disorders Clinical Trials 19
  • Clinical Trials by Phase in E7 Countries 21
  • Clinical Trials in E7 Countries by Trial Status 22
  • Clinical Trials by Phase 23
  • In Progress Trials by Phase 24
  • Clinical Trials by Trial Status 25
  • Clinical Trials by End Point Status 26
  • Subjects Recruited Over a Period of Time 27
  • Clinical Trials by Sponsor Type 28
  • Prominent Sponsors 29
  • Top Companies Participating in Ear Infections Therapeutics Clinical Trials 31
  • Prominent Drugs 33
  • Clinical Trial Profile Snapshots 34

Appendix 52

  • Abbreviations 52
  • Definitions 52
  • Research Methodology 53
  • Secondary Research 53
  • About GlobalData 54
  • Contact Us 54
  • Source 54

List of Tables

List of Tables

  • Ear Infections Therapeutics, Global, Clinical Trials by Region, 2017* 7
  • Ear Infections Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 9
  • Ear Infections Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 10
  • Ear Infections Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2017* 11
  • Ear Infections Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 12
  • Ear Infections Therapeutics Clinical Trials, North America, Top Countries, 2017* 13
  • Ear Infections Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2017* 14
  • Proportion of Ear Infections to Ear Nose Throat Disorders Clinical Trials, G7 Countries (%), 2017* 16
  • Ear Infections Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 17
  • Ear Infections Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 18
  • Proportion of Ear Infections to Ear Nose Throat Disorders Clinical Trials, E7 Countries (%), 2017* 20
  • Ear Infections Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 21
  • Ear Infections Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 22
  • Ear Infections Therapeutics, Global, Clinical Trials by Phase, 2017* 23
  • Ear Infections Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 24
  • Ear Infections Therapeutics, Global, Clinical Trials by Trial Status, 2017* 25
  • Ear Infections Therapeutics Clinical Trials, Global, by End Point Status, 2017* 26
  • Ear Infections Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 27
  • Ear Infections Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 28
  • Ear Infections Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 30
  • Ear Infections Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 32
  • Ear Infections Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 33

List of Figures

List of Figures

  • Ear Infections Therapeutics, Global, Clinical Trials by Region (%), 2017* 7
  • Ear Infections Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 8
  • Ear Infections Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 10
  • Ear Infections Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2017* 11
  • Ear Infections Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 12
  • Ear Infections Therapeutics Clinical Trials, North America, Top Countries (%), 2017* 13
  • Proportion of Ear Infections to Ear Nose Throat Disorders Clinical Trials, G7 Countries (%), 2017* 15
  • Ear Infections Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 17
  • Ear Infections Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 18
  • Proportion of Ear Infections to Ear Nose Throat Disorders Clinical Trials, E7 Countries (%), 2017* 19
  • Ear Infections Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 21
  • Ear Infections Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 22
  • Ear Infections Therapeutics, Global, Clinical Trials by Phase (%), 2017* 23
  • Ear Infections Therapeutics, Global, Clinical Trials In Progress by Phase, 2017* 24
  • Ear Infections Therapeutics, Global, Clinical Trials by Trial Status, 2017* 25
  • Ear Infections Therapeutics Clinical Trials, Global, by End Point Status, 2017* 26
  • Ear Infections Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 27
  • Ear Infections Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 28
  • Ear Infections Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 29
  • Ear Infections Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 31
  • Ear Infections Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 33
  • GlobalData Methodology 53
Back to Top